ANNEX B BIOGRAPHIES

KEYNOTE SPEAKER:

Mr GOH Chok Tong is the Senior Minister of the Republic of Singapore . He is concurrently Chairman of the Monetary Authority of Singapore . Mr Goh served as Prime Minister from November 1990 to August 2004, when he stepped aside to pave the way for political self-renewal. He was First Deputy Prime Minister between 1985 and November 1990. Mr Goh has been a member of the Singapore Cabinet since 1979, having held various portfolios including Trade and Industry, Health and Defence. Between 1977 and 1979, he was Senior Minister of State for Finance. He has been a Member of Parliament since 1976. Prior to joining politics, Mr Goh was Managing Director of Neptune Orient Lines.

SINGAPORE CONFERENCE MODERATOR:

Mr HO Kwon Ping is Executive Chairman of the Banyan Tree Group , which owns both listed and private companies engaged in the development, ownership and operation of hotels, resorts, spas, residen tial homes, retail galleries and other lifestyle activities in the region. Mr Ho is also Chairman of the family-owned Wah Chang Group; Chairman of Singapore Management University, the third national university in Singapore; and Chairman of MediaCorp, Singapore's national broadcaster.

SINGAPORE CONFERENCE PANELLISTS:

Dr LEE Boon Yang is the Minister for Information, Communications & the Arts, Republic of Singapore . He first won his seat in Parliament in the General Elections of 1984. He has since held political appointments in the Ministries of Environment, Communications & Information, Finance, Home Affairs, Trade & Industry, National Development, Defence, Prime Minister's Office and Labour/Manpower.

Dr Vivian BALAKRISHNAN is the Acting Minister for Community Development, Youth & Sports and Senior Minister of State for Trade & Industry, Republic of Singapore . Dr Balakrishnan was elected as a Member of Parliament in the 2001 General Election. He was also appointed Chairman of the "Remaking Singapore" committee in February 2002, and Chairman of the National Youth Council in July 2003. Prior to embarking on his political career, Dr Balakrishnan was the Chief Executive Officer of the Singapore General Hospital.

Mr Iain FERGUSON CBE is the Chief Executive of Tate & Lyle PLC , a world-leading manufacturer of renewable food and industrial ingredients with headquarters in London. The Group has 6,700 employees and 60 plants in 28 countries. Mr Ferguson is an active member in many key industry groups and public/governmental bodies. He is also a Non-Executive Director of Sygen International plc. Mr Ferguson was awarded a Commander of the British Empire for services to the food industry by the Queen in 2003.

Sir Peter MIDDLETON GCB is President of the British Bankers Association . He is also Chairman of Camelot Group plc, Chairman of the Barclays Group Asia Pacific Advisory Committee, Deputy Chairman of United Utilities, Chairman of Sheffield Urban Regeneration Company, Chairman of CEDR (Centre for Effective Dispute Resolution), Chairman of Reyniers & Co and a Member of the International Advisory Panel of the Monetary Authority of Singapore.

Mr SIM Wong Hoo is the Founder, Chairman and Chief Executive Officer of Creative Technology Ltd , the world's leading provider of digital lifestyle entertainment products and peripherals for personal computers. Creative is best known for its pace- setting Sound Blaster audio card, the brainchild of Mr Sim. Today, Creative is moving into another new market segment that it is again pioneering - the Personal Digital Entertainment (PDE) product market, with the highly acclaimed Zen and MuVo range of portable audio players.

Mr Andrew WITTY became President, Pharmaceuticals Europe for GlaxoSmithKline in January 2003 and is a member of the Corporate Executive Team. He joined Glaxo UK in 1985, and has held various positions in the UK, South Africa, the United States and the Far East. During 2002 and 2003, he was a Board Member of the Singapore Economic Development Board and the Singapore Land Authority Board. He also served as Economic Adviser to the Governor of Guangzhou, China. Andrew is a member of the Working Group of Pharma Futures and sits on the Imperial College Commercialisation Advisory Board.